Pro
Healthcare-focused private equity firm Somerset Indus Capital Partners has checked out of all the investments from its first fund as it marked an exit from its nine-year-old bet on a nutraceutical company through a buyback transaction. The PE firm, which is raising about $250 million for its third fund, has sold ......
